Strategy and Vision
Accelerating clinical trials
Creating a globally competitive location for research delivery
Increasing patient involvement and improving access for all patients
TARGET has pleasure contributing to the overall vision of the Cancer Trial program at King's Health Center, providing essential support for staff, to accelerate the translational research, create a globally competitive location for research, increase patient involvement and access
Translation of scientific advances from laboratory to clinic is vital. The cancer team drives closer cooperation with Partner Centers and Industry Collaborators, to ensure translational relationships with discovery teams and industry can reach patients in the form of trials in the Cancer Center at Guy's
The Cancer Center at Guy's trial program is supported by exceptional facilities, operating since 2016 and offers a world class environment to deliver all forms of clinical trials for all kind of cancer care, specially for new treatments in the form of clinical trials
Through Professor Spicer's involvement in the national network for clinical Trialists, including his leadership of the Kings's Experimental Cancer Medical Center and his recent role as
Chair of the Paediatric ECMC Strategy Group, King's contributed to the improvement of the UK infrastructure in this field
King's serves a diverse urban population and aims to priorities studies addressing clinical problems, specially prevalent in their patients, such as lung and hepatocellular (liver) cancer
King's has a longstanding experience of engagements with a supportive and active King's Cancer PPI (Public and Patient Involvement) forum
Their work allows them to continue translating great science from bench to bedside
A young persons's destination should not be limited by their start in life